Pramyothin Pornpoj, Limpattanachart Vichol, Dawilai Suwitcha, Sarasak Rungnapha, Sukaruttanawong Chariya, Chaiyasoot Kusuma, Keawtanom Songsri, Yamwong Preyanuj
Endocr Pract. 2017 Aug;23(8):915-922. doi: 10.4158/EP171792.OR. Epub 2017 Jun 14.
To determine whether fat free mass (FFM) is independently associated with the metabolically healthy obesity (MHO) phenotype, the metabolic syndrome (MS), and type 2 diabetes (T2D) in obese Asian adults.
Obese patients (body mass index [BMI] ≥25 kg/m) seeking weight management at an academic medical center from 2007 to 2016 were included. FFM was measured by bioelectrical impedance.
Of the 552 patients (67.0% female, median age 40.5 years, median BMI 38.3 kg/m), MHO was present in 19%, MS in 55.4%, and T2D in 32.6%. In multivariate models, higher fat-free mass index (FFMI) was independently associated with the metabolically abnormal obesity (MAO) phenotype, (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.09-1.37), and increased risk of MS (OR 1.12, 95% CI 1.03-1.22) in women but not in men. Older age was independently associated with the MAO phenotype (OR 1.06, 95% CI 1.04-1.09 in women; OR 1.06, 95% CI 1.02-1.09 in men), MS (OR 1.05, 95% CI 1.03-1.06 in women; OR 1.05, 95% CI 1.02-1.07 in men), and T2D (OR 1.07, 95% CI 1.05-1.09 in women; OR 1.06, 95% CI 1.04-1.09 in men). Waist-hip ratio was independently associated with the MAO phenotype in men (OR 1.08, 95% CI 1.01-1.15), while waist circumference was associated with T2D in women (OR 1.03, 95% CI 1.01-1.05).
Older age, central fat distribution, and-in contrast to previous findings-an increase in FFMI among women were independent predictors of adverse metabolic health in this cohort of middle-aged obese Asian adults. Further studies are required to elucidate underlying mechanisms and therapeutic implications of these findings.
BIA = bioelectrical impedance analysis BMI = body mass index CI = confidence interval DXA = dual-energy X-ray absorptiometry FFM = fat-free mass FFMI = fat-free mass index FM = fat mass HbA1c = glycated hemoglobin A1c MAO = metabolically abnormal obesity MHO = metabolically healthy obesity MS = metabolic syndrome OR = odds ratio T2D = type 2 diabetes WC = waist circumference WHR = waist-hip-ratio.
确定在肥胖的亚洲成年人中,去脂体重(FFM)是否与代谢健康型肥胖(MHO)表型、代谢综合征(MS)和2型糖尿病(T2D)独立相关。
纳入2007年至2016年在一家学术医疗中心寻求体重管理的肥胖患者(体重指数[BMI]≥25kg/m²)。通过生物电阻抗测量去脂体重。
在552例患者中(女性占67.0%,中位年龄40.5岁,中位BMI 38.3kg/m²),MHO占19%,MS占55.4%,T2D占32.6%。在多变量模型中,较高的去脂体重指数(FFMI)与代谢异常型肥胖(MAO)表型独立相关(比值比[OR]1.22,95%置信区间[CI]1.09 - 1.37),且女性患MS的风险增加(OR 1.12,95% CI 1.03 - 1.22),而男性则不然。年龄较大与MAO表型独立相关(女性OR 1.06,95% CI 1.04 - 1.09;男性OR 1.06,95% CI 1.02 - 1.09)、MS(女性OR 1.05,95% CI 1.03 - 1.06;男性OR 1.05,95% CI 1.02 - 1.07)和T2D(女性OR 1.07,95% CI 1.05 - 1.09;男性OR 1.06,95% CI 1.04 - 1.09)。腰臀比与男性的MAO表型独立相关(OR 1.08,95% CI 1.01 - 1.15),而腰围与女性的T2D相关(OR 1.03,95% CI 1.01 - 1.05)。
在这组中年肥胖亚洲成年人中,年龄较大、中心性脂肪分布以及与先前研究结果相反的女性FFMI增加是代谢健康不良的独立预测因素。需要进一步研究以阐明这些发现的潜在机制和治疗意义。
BIA = 生物电阻抗分析;BMI = 体重指数;CI = 置信区间;DXA = 双能X线吸收法;FFM = 去脂体重;FFMI = 去脂体重指数;FM = 脂肪量;HbA1c = 糖化血红蛋白A1c;MAO = 代谢异常型肥胖;MHO = 代谢健康型肥胖;MS = 代谢综合征;OR = 比值比;T2D = 2型糖尿病;WC = 腰围;WHR = 腰臀比